Correlation Between Scpharmaceuticals and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Unicycive Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Unicycive Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Unicycive Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Scpharmaceuticals and Unicycive is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Unicycive Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Unicycive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.78 times less risky than Unicycive Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Unicycive Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 117.00 in Unicycive Therapeutics on August 26, 2024 and sell it today you would lose (64.00) from holding Unicycive Therapeutics or give up 54.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Unicycive Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Unicycive Therapeutics |
Scpharmaceuticals and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Unicycive Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. HCW Biologics | Unicycive Therapeutics vs. Scpharmaceuticals | Unicycive Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |